Novel strategy for immunomodulation: Dissolving microneedle array encapsulating thymopentin fabricated by modified two-step molding technology

Yin, 2006, Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin, J. Control. Release, 116, 337, 10.1016/j.jconrel.2006.09.015

Zheng, 2006, Thymopentin-loaded pH-sensitive chitosan nanoparticles for oral administration: preparation, characterization, and pharmacodynamics, J Nanosci. Nanotechno., 6, 2936, 10.1166/jnn.2006.451

Singh, 1998, Thymopentin and splenopentin as immunomodulators, Immunol. Res., 17, 345, 10.1007/BF02786456

Merigan, 1996, The prognostic significance of serum viral load, codon 215 reverse transcriptase mutation and CD4+ T cells on progression of HIV disease in a double-blind study of thymopentin, Aids, 10, 159, 10.1097/00002030-199602000-00005

Ambrogi, 1992, CD5+ B Lymphocytes and T-cell Subsets in a Case of Juvenile Rheumatoid Arthritis, Ann. NY Acad. Sci., 651, 564, 10.1111/j.1749-6632.1992.tb24663.x

Sundal, 1994, Thymopentin treatment of rheumatoid arthritis, Arzneimittel Forsch., 44, 1145

Wu, 2014, Thymopentin nanoparticles engineered with high loading efficiency, improved pharmacokinetic properties, and enhanced immunostimulating effect using soybean phospholipid and PHBHHx polymer, Mol. Pharm., 11, 3371, 10.1021/mp400722r

Conti, 1997, Thymopentin loaded microsphere preparation by w/o/w emulsion technique: in vitro/ex vivo evaluation, J. Microencapsul., 14, 303, 10.3109/02652049709051134

He, 2008, Preparation and evaluation of poly-butylcyanoacrylate nanoparticles for oral delivery of thymopentin, J. Pharm. Sci., 97, 2250, 10.1002/jps.21148

Zhang, 2010, Novel thymopentin release systems prepared from bioresorbable PLA–PEG–PLA hydrogels, Int. J. Pharm., 386, 15, 10.1016/j.ijpharm.2009.10.045

van der Maaden, 2012, Microneedle technologies for (trans) dermal drug and vaccine delivery, J. Control. Release, 161, 645, 10.1016/j.jconrel.2012.01.042

Cheung, 2014, Microneedles for drug delivery: trends and progress, Drug Deliv., 1–17

Kim, 2012, Microneedles for drug and vaccine delivery, Adv. Drug Deliver. Rev., 64, 1547, 10.1016/j.addr.2012.04.005

Suh, 2014, Microneedle patches for vaccine delivery, Clin. Exp. Vaccine Res., 3, 42, 10.7774/cevr.2014.3.1.42

Hirschberg, 2010, Bioneedles as alternative delivery system for hepatitis B vaccine, J. Control. Release, 147, 211, 10.1016/j.jconrel.2010.06.028

Hong, 2013, Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine, Drug. Des. Dev. Ther., 7, 945

M.R. Prausnitz, J.A. Mikszta, M. Cormier, A.K. Andrianov, Microneedle-based vaccines, in: Vaccines for Pandemic Influenza, Springer, 2009, pp. 369–393.

Ding, 2009, Immune modulation by adjuvants combined with diphtheria toxoid administered topically in BALB/c mice after microneedle array pretreatment, Pharm. Res., 26, 1635, 10.1007/s11095-009-9874-6

Wendorf, 2011, Transdermal delivery of macromolecules using solid-state biodegradable microstructures, Pharm. Res., 28, 22, 10.1007/s11095-010-0174-y

Miyano, 2005, Sugar micro needles as transdermic drug delivery system, Biomed. Microdevices, 7, 185, 10.1007/s10544-005-3024-7

Donnelly, 2009, Processing difficulties and instability of carbohydrate microneedle arrays, Drug. Dev. Ind. Pharm., 35, 1242, 10.1080/03639040902882280

Sullivan, 2010, Dissolving polymer microneedle patches for influenza vaccination, Nat. Med., 16, 915, 10.1038/nm.2182

Donnelly, 2011, Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique, Pharm. Res., 28, 41, 10.1007/s11095-010-0169-8

Donnelly, 2010, Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety, Drug Deliv., 17, 187, 10.3109/10717541003667798

Wang, 2015, Investigation on fabrication process of dissolving microneedle arrays to improve effective needle drug distribution, Eur. J. Pharm. Sci., 66, 148, 10.1016/j.ejps.2014.09.011

Yin, 2007, Stability evaluation of thymopentin in solution by RP-HPLC, J. Shenyang Pharm. Univ., 24, 89

Jin, 2011, Chitosan–glutathione conjugate-coated poly(butyl cyanoacrylate) nanoparticles: promising carriers for oral thymopentin delivery, Carbohyd. Polym., 86, 51, 10.1016/j.carbpol.2011.03.050

M. Egawa, T. Hirao, M. Takahashi. In vivo estimation of stratum corneum thickness from water concentration profiles obtained with Ranman spectroscopy, Acta Derm.-Venereol. 87 (2007) 4-8.

Kaushik, 2001, Lack of pain associated with microfabricated microneedles, Anesthesia & Analgesia, 92, 502, 10.1213/00000539-200102000-00041

Loizidou, 2015, Structural characterisation and transdermal delivery studies on sugar microneedles: experimental and finite element modelling analyses, Eur. J. Pharm. Biophar., 89, 224, 10.1016/j.ejpb.2014.11.023

Cowley, 2005, CD4− CD8− T cells control intracellular bacterial infections both in vitro and in vivo, J. Exp. Med., 202, 309, 10.1084/jem.20050569

Wang, 2006, Pharmacokinetics, toxicity of nasal cilia and immunomodulating effects in Sprague-Dawley rats following intranasal delivery of thymopentin with or without absorption enhancers, Peptides, 27, 826, 10.1016/j.peptides.2005.09.008

Treitinger, 2000, Decreased antioxidant defence in individuals infected by the human immunodeficiency virus, Eur. J. Clin. Invest., 30, 454, 10.1046/j.1365-2362.2000.00642.x

Bal, 2008, In vivo assessment of safety of microneedle arrays in human skin, Eur. J. Pharm. Sci., 35, 193, 10.1016/j.ejps.2008.06.016

Noh, 2010, In vitro characterization of the invasiveness of polymer microneedle against skin, Int J. Pharm., 397, 201, 10.1016/j.ijpharm.2010.06.050

Gupta, 2012, Rapid local anesthesia in human subjects using minimally invasive microneedles, Clin. J. Pain, 28, 129, 10.1097/AJP.0b013e318225dbe9